Practice
Open Access
Immediate reactions after mRNA SARS-CoV-2 vaccination
Samira Jeimy, Tiffany Wong and Christine Song
CMAJ December 06, 2021 193 (48) E1842; DOI: https://doi.org/10.1503/cmaj.211581
Samira Jeimy
Division of Clinical Immunology and Allergy (Jeimy), Department of Medicine, Western University, London, Ont.; Division of Allergy and Immunology (Wong), Department of Pediatrics, The University of British Columbia, Vancouver, BC; Division of Clinical Immunology and Allergy (Song), Department of Medicine, University of Toronto, Toronto, Ont.
MD PhDTiffany Wong
Division of Clinical Immunology and Allergy (Jeimy), Department of Medicine, Western University, London, Ont.; Division of Allergy and Immunology (Wong), Department of Pediatrics, The University of British Columbia, Vancouver, BC; Division of Clinical Immunology and Allergy (Song), Department of Medicine, University of Toronto, Toronto, Ont.
MDChristine Song
Division of Clinical Immunology and Allergy (Jeimy), Department of Medicine, Western University, London, Ont.; Division of Allergy and Immunology (Wong), Department of Pediatrics, The University of British Columbia, Vancouver, BC; Division of Clinical Immunology and Allergy (Song), Department of Medicine, University of Toronto, Toronto, Ont.
MDIn this issue
Article tools
Immediate reactions after mRNA SARS-CoV-2 vaccination
Samira Jeimy, Tiffany Wong, Christine Song
CMAJ Dec 2021, 193 (48) E1842; DOI: 10.1503/cmaj.211581
Jump to section
- Article
- Anaphylaxis after mRNA vaccination for SARS-CoV-2 is rare
- An immediate reaction to the first dose of the mRNA vaccines should not preclude administration of the second dose
- Excipient skin testing is not useful3,4
- Reactions to mRNA SARS-CoV-2 vaccines may not be mediated by IgE antibodies
- Rapid allergist assessment for mRNA vaccine administration is now accessible across Canada
- Footnotes
- References
- Responses
- Metrics